The FDA-cleared system uses artificial intelligence to create interactive 3D models from standard medical scans for preoperative planning and intraoperative guidance.
Surgical Theater has announced that its US Food and Drug Administration-cleared surgical eXperiential Reality (XR) visualization platform has been used in more than 50,000 procedures across spine, cranial, and other specialties. The company’s system uses artificial intelligence to convert traditional medical imaging into immersive, clinically integrated 3D environments.
The platform, which includes SyncAR, PlanXR, and ConveyXR, allows surgeons to view a patient’s anatomy from multiple angles and rehearse procedures in advance. In the operating room, the system integrates with surgical navigation, microscopes, and existing workflow to provide surgeons with real-time visibility that aligns with their preoperative plan.
“Our technology has now guided surgeons over 50,000 times, but the impact is measured far beyond numbers,” says Alon Zuckerman, president of Surgical Theater, in a release. “Each case represents a patient whose surgeon walked them through their condition in the clinic, practiced and planned the procedure in advance, and then carried that plan into the operating room with deeper insight and greater precision.”
The company plans to showcase new capabilities at the upcoming Congress of Neurological Surgeons and North American Spine Society congresses. Alongside the milestone, Surgical Theater also introduced a refreshed brand identity and announced that new innovations are planned for launch later this year.
“Our role is to give surgeons the tools to honor that trust with the best possible precision and care, while standing shoulder to shoulder with hospitals to ensure they have technology that empowers them today and prepares them for tomorrow,” says Zuckerman, in a release.
Photo caption: Surgical Theater’s eXperiential Reality (XR) visualization platform
Photo credit: Surgical Theater
